IDA SUTHERLAND: Open Payments
NPI 1003925108 · RADFORD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,697 in 86 payments from 23 companies in 2025. Trend: 2023 $1,358 · 2024 $1,717 · 2025 $1,697
Food & beverage: $1,697
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $202 |
| PFIZER INC. | 14 | $193 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $168 |
| Otsuka America Pharmaceutical, Inc. | 6 | $155 |
| AstraZeneca Pharmaceuticals LP | 7 | $140 |
| GlaxoSmithKline, LLC. | 6 | $116 |
| Vanda Pharmaceuticals Inc. | 3 | $84 |
| Lundbeck LLC | 3 | $78 |
| Janssen Pharmaceuticals, Inc | 3 | $76 |
| Phathom Pharmaceuticals, Inc. | 3 | $64 |
Products named: REXULTI, CAPLYTA, NURTEC ODT, Ozempic, TRELEGY ELLIPTA, FARXIGA, SPRAVATO, VOQUEZNA.
Industry payments across VA — which companies pay providers there.
